This decision follows a significant decline in ASML's share price, which dropped 30% during July and August. As part of this downgrade, Morgan Stanley also adjusted ASML's stock rating from Overweight to Equal-weight.The downgrade reflects concerns over earnings growth challenges anticipated for 2025-2026, prompting a reduction in the price target for ASML's shares from 925 to 800